Ma DW, Ha J, Yoon KS, Kang I, Choi TG, Kim SS
Based on these data, the IGF-1 drug itself does not cause oncology, but only has a contraindication to use if you already have cancer or its predisposition (high cancer markers)
Aliment Pharmacol Ther 44(4):411421 Haugaard SB et al (2007) Impaired proinsulin secretion before and during oral glucose stimulation in HIV-infected patients who display fat redistribution
We recommend careful patient selection with consideration of frailty status assessment in addition to mRS to optimise clinical outcomes
GHK-Cu (50mg) is a copper-binding peptide renowned for its potent skin and tissue regenerative properties, aiding in wound healing, collagen production, and overall skin health
Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors